Yuan Zhi
Stock Analyst at B. Riley Securities
(1.87)
# 3,368
Out of 5,093 analysts
31
Total ratings
36.67%
Success rate
-5.18%
Average return
Main Sectors:
Stocks Rated by Yuan Zhi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RDNT RadNet | Maintains: Buy | $71 → $87 | $75.85 | +14.70% | 2 | Dec 1, 2025 | |
| RADX Radiopharm Theranostics | Maintains: Buy | $15 → $13 | $4.23 | +207.33% | 2 | Nov 26, 2025 | |
| TNGX Tango Therapeutics | Maintains: Buy | $8 → $14 | $9.12 | +53.51% | 3 | Nov 18, 2025 | |
| CATX Perspective Therapeutics | Maintains: Buy | $12 → $11 | $2.52 | +336.51% | 4 | Nov 18, 2025 | |
| MIR Mirion Technologies | Reiterates: Buy | $17 → $22 | $25.20 | -12.70% | 3 | Jul 23, 2025 | |
| TOI The Oncology Institute | Initiates: Buy | $6 | $3.38 | +77.51% | 1 | Jul 16, 2025 | |
| HYPR Hyperfine | Maintains: Buy | $1.2 → $1 | $1.04 | -3.85% | 2 | May 15, 2025 | |
| AGEN Agenus | Maintains: Buy | $42 → $18 | $3.92 | +359.18% | 2 | Aug 14, 2024 | |
| CYRX Cryoport | Upgrades: Buy | $19 → $15 | $9.99 | +50.15% | 4 | Jul 31, 2024 | |
| CTSO Cytosorbents | Reiterates: Buy | $3 | $0.75 | +300.05% | 1 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $61 → $79 | $35.60 | +121.91% | 3 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $16 | $1.43 | +1,018.88% | 4 | Dec 11, 2023 |
RadNet
Dec 1, 2025
Maintains: Buy
Price Target: $71 → $87
Current: $75.85
Upside: +14.70%
Radiopharm Theranostics
Nov 26, 2025
Maintains: Buy
Price Target: $15 → $13
Current: $4.23
Upside: +207.33%
Tango Therapeutics
Nov 18, 2025
Maintains: Buy
Price Target: $8 → $14
Current: $9.12
Upside: +53.51%
Perspective Therapeutics
Nov 18, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $2.52
Upside: +336.51%
Mirion Technologies
Jul 23, 2025
Reiterates: Buy
Price Target: $17 → $22
Current: $25.20
Upside: -12.70%
The Oncology Institute
Jul 16, 2025
Initiates: Buy
Price Target: $6
Current: $3.38
Upside: +77.51%
Hyperfine
May 15, 2025
Maintains: Buy
Price Target: $1.2 → $1
Current: $1.04
Upside: -3.85%
Agenus
Aug 14, 2024
Maintains: Buy
Price Target: $42 → $18
Current: $3.92
Upside: +359.18%
Cryoport
Jul 31, 2024
Upgrades: Buy
Price Target: $19 → $15
Current: $9.99
Upside: +50.15%
Cytosorbents
May 15, 2024
Reiterates: Buy
Price Target: $3
Current: $0.75
Upside: +300.05%
Feb 1, 2024
Maintains: Buy
Price Target: $61 → $79
Current: $35.60
Upside: +121.91%
Dec 11, 2023
Maintains: Buy
Price Target: $20 → $16
Current: $1.43
Upside: +1,018.88%